Quote:Using insurance ... to cover predictable and routine costs is merely a waste of money
In the case of breast cancer in women, this disorder has a high probability of occurring in women who carry a specific gene. Today, this gene is well known and assays for it's presence are routinely used in certain ethnic groups who may be at risk for breast cancer.
In addition to gene ID , especially in women who lack the gene or even a family history of breast cancer, there is still a probability of a woman developing breast cancer as she ages .
Thus, for all women it is critical to have regular mammograms, have their breasts examined manually by an MD ( and do self-examination), know their family history and know whether their ethnicity is tied to a specific gene mutation ( leading to breast cancer).
Insurance will pay for a yearly mammogram. For specific ethnic groups , at high risk for developing breast cancer, insurance will also pay for a genetic molecular analysis.
Insurance also pays for a yearly physical with an internist, who will also conduct a manual breast exam.
In case, breast cancer is detected, insurance pays ( if needed)for surgery, a biopsy and chemotherapy.
It's been said over and over again, that the likelihood of an average woman t developing breast cancer ( in the US) is about 1/8 ( depending on the report source). It is obvious, that each and every test listed above is routine and cost effective when preserving the health and well being of each and every woman. In the absence of affordable insurance, the only women (in the US)who could afford identification and treatment of breast cancer ( or any cancer for that matter) would be a select few from the upper middle class and the ultra wealthy.
Thus, coverage of predictable and routine costs, offered by an affordable health plan is not a waste of money, especially when it involves early detection and treatment of breast cancer in all women, because
the life and wellbeing of each and every woman matters.